Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chintan V Dave

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
BMC Cardiovascular Disorders|May 30, 2024
Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013-2021Jimmy Gonzalez, Chintan V Dave
JAMA Internal Medicine|August 19, 2024
Further Study Needed on Antihypertensive Medications and Fracture Risks-In ReplyChintan V Dave, Michelle C Odden
Journal of the American Geriatrics Society|August 30, 2024
Many studies, but little certainty about the effects of statin discontinuation on outcomesMichelle C Odden, Chintan V Dave
Diabetology & Metabolic Syndrome|November 29, 2022
Healthcare costs associated with comorbid cardiovascular and renal conditions among persons with diabetes, 2008-2019Chintal H Shah, Chintan V Dave
JAMA Internal Medicine|September 4, 2019
Association of Sodium-Glucose Cotransporter 2 Inhibitor Treatment With Risk of Hospitalization for Fournier Gangrene Among MenChintan V Dave, Sebastian Schneeweiss, Elisabetta Patorno
Diabetes, Obesity & Metabolism|September 13, 2018
Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitorsChintan V Dave, Sebastian Schneeweiss, Elisabetta Patorno
The New England Journal of Medicine|December 28, 2017
Prices of Generic Drugs Associated with Numbers of ManufacturersChintan V Dave, Abraham Hartzema, Aaron S Kesselheim
Journal of General Internal Medicine|May 9, 2019
Changes in Price for Generic Drugs in the USA, 2008-2016Chintan V Dave, Gregory Brill, Aaron S Kesselheim
American Journal of Hypertension|July 28, 2018
Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant HypertensionAndrew Y Hwang, Chintan V Dave, Steven M Smith
JAMA Network Open|May 6, 2024
Racial and Ethnic Disparities in Initiation of Direct Oral Anticoagulants Among Medicare BeneficiariesKamika R Reynolds, Farzin Khosrow-Khavar, Chintan V Dave
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
BMC Cardiovascular Disorders|May 30, 2024
Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013-2021Jimmy Gonzalez, Chintan V Dave
JAMA Internal Medicine|August 19, 2024
Further Study Needed on Antihypertensive Medications and Fracture Risks-In ReplyChintan V Dave, Michelle C Odden
Journal of the American Geriatrics Society|August 30, 2024
Many studies, but little certainty about the effects of statin discontinuation on outcomesMichelle C Odden, Chintan V Dave
Diabetology & Metabolic Syndrome|November 29, 2022
Healthcare costs associated with comorbid cardiovascular and renal conditions among persons with diabetes, 2008-2019Chintal H Shah, Chintan V Dave
JAMA Internal Medicine|September 4, 2019
Association of Sodium-Glucose Cotransporter 2 Inhibitor Treatment With Risk of Hospitalization for Fournier Gangrene Among MenChintan V Dave, Sebastian Schneeweiss, Elisabetta Patorno
Diabetes, Obesity & Metabolism|September 13, 2018
Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitorsChintan V Dave, Sebastian Schneeweiss, Elisabetta Patorno
The New England Journal of Medicine|December 28, 2017
Prices of Generic Drugs Associated with Numbers of ManufacturersChintan V Dave, Abraham Hartzema, Aaron S Kesselheim
Journal of General Internal Medicine|May 9, 2019
Changes in Price for Generic Drugs in the USA, 2008-2016Chintan V Dave, Gregory Brill, Aaron S Kesselheim
American Journal of Hypertension|July 28, 2018
Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant HypertensionAndrew Y Hwang, Chintan V Dave, Steven M Smith
JAMA Network Open|May 6, 2024
Racial and Ethnic Disparities in Initiation of Direct Oral Anticoagulants Among Medicare BeneficiariesKamika R Reynolds, Farzin Khosrow-Khavar, Chintan V Dave
Pageof 5